AXIS 2: AX200 for the Treatment of Ischemic Stroke

NCT00927836 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

BIOLOGICAL: Filgrastim
DRUG: Sodium chloride solution

Sponsor

Sygnis Bioscience GmbH & Co KG